Pluxee Shares Drop 3% Following JP Morgan's Target Reduction
Pluxee's stock experienced significant selling pressure this Wednesday at midday, falling by 3.15% to 10.45 euros in an otherwise upward-trending Parisian market. This recent downward trend occurs as JP Morgan has just lowered its price target on the stock. Over the past year, the employee benefits specialist has now declined by more than 52%.
JP Morgan Lowers Price Target on Pluxee
On March 18th, American bank JP Morgan revised its price target on Pluxee downwards, reducing it from 18.00 euros to 15.50 euros, while maintaining a neutral recommendation on the stock. Despite this significant reduction of 13.9%, the new target suggests a potential rebound of approximately 48% compared to the current price of 10.45 euros.
This recalibration reflects the deteriorated trajectory of the stock in recent months. Pluxee has seen a decline of 21.6% over three months and 2.1% in just the last week, indicating a continuous erosion in valuation. The publication of the first half of 2026 results, expected on April 16th, will be a crucial moment to assess the operational dynamics of the group formed from the spin-off of Sodexo.
Technical Analysis: Pluxee Nears Support Threshold
From a technical standpoint, today's drop brings Pluxee closer to its support level at 10.41 euros, now only four cents away. A downward breach of this zone could pave the way for a new phase of decline, in a context where the stock is significantly below its 50-day (11.32 euros) and 200-day (15.01 euros) moving averages. This substantial gap with the 200-day moving average, over 30%, illustrates the depth of the bearish trend on the stock.
The Relative Strength Index (RSI) stands at 47, an intermediate level that indicates neither an oversold condition nor a rebound dynamic. Pluxee moves contrary to the CAC 40, which is up by 0.89% in the session, and the SBF 120, which is up by 0.93%. For comparison, Capgemini is up by 0.43% and Sartorius Stedim Biotech is advancing by 1.49% at the same time, highlighting the isolation of the stock in today's session.
